Automated description from the Alliance of Genome Resources
Predicted to have cholesterol binding activity. Involved in negative regulation of lipoprotein lipid oxidation and response to reactive oxygen species. Predicted to localize to several cellular components, including the cytosolic ribosome; neuronal cell body; and perinuclear region of cytoplasm. Human ortholog(s) of this gene implicated in obesity and type 2 diabetes mellitus. Is expressed in several structures, including central nervous system; embryo mesenchyme; lip; sensory organ; and skeleton. Orthologous to human APOD (apolipoprotein D).